Australia appears to be experience innovative therapy for weight issues: Retatrutide. This dual molecule – working on both GLP-1 and GIP receptors – shows significant outcomes in clinical studies, suggesting considerable reductions in weight. While approval is pending with the Therapeutic Goods Administration (TGA), many individuals dealing wit